Jiang Linlin, Huang Jia, Li Lin, Chen Yaxiao, Chen Xiaoli, Zhao Xiaomiao, Yang Dongzi
Department of Obstetrics and Gynecology (L.J., J.H., L.L., Y.C., X.C., X.Z., D.Y.), Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120 China.
J Clin Endocrinol Metab. 2015 May;100(5):E729-38. doi: 10.1210/jc.2014-3827. Epub 2015 Feb 19.
MicroRNAs (miRNAs) are small, noncoding RNAs that negatively regulate gene expression post-transcriptionally. Whether differently expressed miRNAs contribute to promoting granulosa cell proliferation in polycystic ovarian syndrome disease (PCOS) remains unknown.
We explored whether certain miRNAs are involved in the ovarian dysfunction of PCOS and the mechanism of increased granulosa cells proliferation. Patients and Cells: miRNA expression was analyzed in excised ovarian cortexes from 16 women with PCOS and 8 non-PCOS. An immortalized human granulosa (KGN) cell was used for the mechanism study.
Expressions of miRNAs in ovarian cortexes were measured using qRT-PCR and KGN granulosa cells were cultured for proliferation assays after overexpression or inhibition of miR-93 or after insulin treatment. Bioinformatics were used to identify the potential miRNA targets. Protein expression analysis, luciferase assays, and rescue assays were used to confirm the substrate of miR-93.
MiR-93 expression was higher in PCOS ovarian cortex and its identified target, CDKN1A, was downregulated. MiR-93 overexpression promoted cell proliferation and G1 to S transition. Knocking down CDKN1A promoted cell growth and cell cycle progression in granulosa cells, and CDKN1A re-introduction reversed the promotional role of miR-93. High concentrations of insulin induced upregulation of miR-93, stimulated KGN cells proliferation and reduced CDKN1A expression.
miR-93 was increased in PCOS granulosa cells and targeted CDKN1A to promote proliferation and cell cycle progression. Insulin could upregulate the expression of miR-93 and stimulate cell proliferation. This might provide a new insight into the dysfunction of granulosa cells in PCOS.
微小RNA(miRNA)是一类小的非编码RNA,可在转录后水平负向调控基因表达。多囊卵巢综合征(PCOS)中差异表达的miRNA是否有助于促进颗粒细胞增殖尚不清楚。
我们探讨了某些miRNA是否参与PCOS的卵巢功能障碍以及颗粒细胞增殖增加的机制。患者和细胞:分析了16例PCOS患者和8例非PCOS患者切除的卵巢皮质中的miRNA表达。使用永生化的人颗粒(KGN)细胞进行机制研究。
使用qRT-PCR检测卵巢皮质中miRNA的表达,并在过表达或抑制miR-93后或胰岛素处理后培养KGN颗粒细胞进行增殖测定。使用生物信息学鉴定潜在的miRNA靶标。使用蛋白质表达分析、荧光素酶测定和拯救试验来确认miR-93的底物。
miR-93在PCOS卵巢皮质中的表达较高,其确定的靶标CDKN1A被下调。miR-93过表达促进细胞增殖和G1期向S期转变。敲低CDKN1A促进颗粒细胞的生长和细胞周期进程,重新引入CDKN1A可逆转miR-93的促进作用。高浓度胰岛素诱导miR-93上调,刺激KGN细胞增殖并降低CDKN1A表达。
miR-93在PCOS颗粒细胞中增加,并靶向CDKN1A促进增殖和细胞周期进程。胰岛素可上调miR-93的表达并刺激细胞增殖。这可能为PCOS颗粒细胞功能障碍提供新的见解。